TC Medical(600763) 搜狐财经· Sou Hu Cai Jing·2025-05-13 10:25Company Overview - Tongce Medical's main business is in medical services, primarily focusing on oral healthcare services [1] - Key hospitals include Hangzhou Oral Hospital Group, Ningbo Oral Hospital Group, and Sanyeh Children's Oral [1] - The company has received multiple accolades, including being named a "China Excellent Management Company" by Deloitte for five consecutive years and ranking in the Zhejiang Merchants National Top 500 for 2022 and 2023 [1] Financial Performance - For Q1 2025, the company reported revenue of 745 million yuan, a year-on-year increase of 5.11% [1] - Net profit for the same period was 184 million yuan, reflecting a year-on-year growth of 6.22% [1] - The sales gross margin stood at 44.21% [1] Market Position - As of May 13, Tongce Medical's stock closed at 41.53 yuan, with a rolling PE ratio of 36.27, marking a 14-day low [1] - The company's total market capitalization is 18.576 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical services sector is 38.57, with a median of 38.12, placing Tongce Medical at 26th in the industry ranking [2] Shareholder Information - As of March 31, 2025, the number of shareholders for Tongce Medical was 84,491, a decrease of 3,759 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]